Skip to Content


In the US, Anakinra (anakinra systemic) is a member of the following drug classes: antirheumatics, interleukin inhibitors and is used to treat Cryopyrin-Associated Periodic Syndromes, Rheumatoid Arthritis, Schnitzler Syndrome and Still's Disease.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories


Disease-modifying antirheumatic drug, DMARD

Anti-inflammatory agent

Interleukin-1 receptor antagonist, IL-1Ra

Chemical Names

Interleukin 1 receptor antagonist (human isoform x reduced), N2-L-metionyl (USAN)

N²-L-Metionylinterleukin 1 receptor antagonist (human isoform x reduced) (WHO)

Foreign Names

  • Anakinrum (Latin)
  • Anakinra (German)
  • Anakinra (French)
  • Anakinra (Spanish)

Generic Names

  • Anakinra (OS: USAN, BAN)
  • Antril (Synergen) (IS)
  • IRAP (IS)
  • rhIL-1ra (IS)

Brand Names

  • Kineret
    A Menarini Australia, Australia; Amgen, Latvia; Amgen Europe, Netherlands; Biovitrum, Spain; Biovitrum, Greece; Biovitrum, Lithuania; Biovitrum AB, Cyprus; Biovitrum AB, Portugal; SOBI, Czech Republic; SOBI, Norway; SOBI, Sweden; Sobi - Swedish Orphan Biovitrum, Germany; Swedish Orphan, Belgium; Swedish Orphan, Iceland; Swedish Orphan, Italy; Swedish Orphan, Lithuania; Swedish Orphan, Poland; Swedish Orphan, Slovenia; Swedish Orphan Biovitrum, Canada; Swedish Orphan Biovitrum, Denmark; Swedish Orphan Biovitrum, Estonia; Swedish Orphan Biovitrum, Finland; Swedish Orphan Biovitrum, France; Swedish Orphan Biovitrum, United Kingdom; Swedish Orphan Biovitrum, Netherlands; Swedish Orphan Biovitrum, Romania; Swedish Orphan Biovitrum Ltd., Ireland
  • Kineret [pediatric]
    Sobi, Inc, United States
  • Kineret 100mg
    Swedish Orphan, Luxembourg; Swedish Orphan Biovitrum, Israel; Swedish Orphan International, Hungary
  • Kineret 100mg/0,67ml
    Swedish Orphan Biovitrum International, Austria


BANBritish Approved Name
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.